{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:35:02Z","timestamp":1792143302009,"version":"4.4.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1053\/j.jvca.2025.01.012","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T19:21:57Z","timestamp":1736796117000},"page":"988-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Vasoplegia in Heart, Lung, or Liver Transplantation: A Narrative Review"],"prefix":"10.1053","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-7213","authenticated-orcid":false,"given":"Jamel","family":"Ortoleva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Dalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Convissar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic V.","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2025.01.012_bib0001","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/j.jvca.2017.10.032","article-title":"Vasoplegia after cardiovascular procedures\u2014Pathophysiology and targeted therapy","volume":"32","author":"Shaefi","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0002","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: The past, the present, and the future","volume":"22","author":"Levy","year":"2018","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.012_bib0003","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer","year":"2018","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2025.01.012_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ccc.2023.06.002","article-title":"Management of vasoplegic shock in the cardiovascular intensive care unit after cardiac surgery","volume":"40","author":"Suero","year":"2024","journal-title":"Crit Care Clin"},{"key":"10.1053\/j.jvca.2025.01.012_bib0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4274\/TJAR.2023.221093","article-title":"Vasoplegic syndrome and anaesthesia: A narrative review","volume":"51","author":"G\u00f6kdemir","year":"2023","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"10.1053\/j.jvca.2025.01.012_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14797\/mdcvj.1245","article-title":"Vasoplegia: A review","volume":"19","author":"Ratnani","year":"2023","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1053\/j.jvca.2025.01.012_bib0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.aan.2022.07.010","article-title":"Updates in the management of perioperative vasoplegic syndrome","volume":"40","author":"Brennan","year":"2022","journal-title":"Adv Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0008","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5152\/eurasianjmed.2022.20394","article-title":"Vasoplegia: Mechanism and management following cardiopulmonary bypass","volume":"54","author":"Muhammad","year":"2022","journal-title":"Eurasian J Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0009","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1111\/jocs.15805","article-title":"Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management","volume":"36","author":"Datt","year":"2021","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120935466","article-title":"Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies","volume":"8","author":"Barnes","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0011","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0012","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00003246-199905000-00025","article-title":"An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock","volume":"27","author":"Grover","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.CCM.0000105118.66983.19","volume":"32","author":"Bakker","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock","volume":"32","author":"L\u00f3pez","year":"2004","journal-title":"Crit. Care Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/0300060517743836","article-title":"Vasoplegia in patients with sepsis and septic shock: Pathways and mechanisms","volume":"46","author":"Burgdorff","year":"2018","journal-title":"J Int Med Res"},{"key":"10.1053\/j.jvca.2025.01.012_bib0016","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery: Review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.012_bib0017","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: Pathophysiology, risk factors and treatment","volume":"349","author":"Omar","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.jvca.2025.01.012_bib0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jclinane.2017.04.017","article-title":"Vasoplegic syndrome: An update on perioperative considerations","volume":"40","author":"Liu","year":"2017","journal-title":"J Clin Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0019","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/j.jvca.2018.11.025","article-title":"A systematic approach to the treatment of vasoplegia based on recent advances in pharmacotherapy","volume":"33","author":"Ortoleva","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"26","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.012_bib0021","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1213\/ANE.0000000000001045","article-title":"Methylene blue: Magic bullet for vasoplegia?","volume":"122","author":"Hosseinian","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0022","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia, a review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0023","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1097\/ALN.0000000000004627","article-title":"Perioperative management of heart transplantation: A clinical review","author":"Nesseler","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2025.01.012_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11748-017-0789-6","article-title":"Risk assessment and outcomes of vasoplegia after cardiac surgery","volume":"65","author":"Tsiouris","year":"2017","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0026","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MAT.0000000000000623","article-title":"Incidence and impact of on-cardiopulmonary bypass vasoplegia during heart transplantation","volume":"64","author":"Truby","year":"2018","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2025.01.012_bib0027","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1053\/j.jvca.2020.12.042","article-title":"Methylene blue for vasoplegia during extracorporeal membrane oxygenation support","volume":"35","author":"Ortoleva","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0028","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.healun.2019.01.003","article-title":"Hydroxocobalamin treatment of refractory vasoplegia in patients with mechanical circulatory support","volume":"38","author":"Cios","year":"2019","journal-title":"J Heart Lung Transpl"},{"key":"10.1053\/j.jvca.2025.01.012_bib0029","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.hrtlng.2010.04.007","article-title":"Characteristics of patients receiving vasopressors","volume":"40","author":"Benbenishty","year":"2011","journal-title":"Heart Lung"},{"key":"10.1053\/j.jvca.2025.01.012_bib0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0031","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/icvts\/ivy352","article-title":"Risk factors for vasoplegia after cardiac surgery: A meta-analysis","volume":"28","author":"Dayan","year":"2019","journal-title":"Interactive CardioVasc Thorac Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0032","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/jocs.15663","article-title":"Risk factors for vasoplegia after coronary artery bypass and valve surgery","volume":"36","author":"Bastopcu","year":"2021","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0033","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejcts.2003.11.032","article-title":"Risk factors and outcomes for \u201cvasoplegia syndrome\u201d following cardiac transplantation","volume":"25","author":"Byrne","year":"2004","journal-title":"Eur J Cardio-Thorac Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0034","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cardfail.2021.11.020","article-title":"Vasoplegia following orthotopic heart transplantation: Prevalence, predictors and clinical outcomes","volume":"28","author":"Batchelor","year":"2022","journal-title":"J Card Fail"},{"key":"10.1053\/j.jvca.2025.01.012_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013108","article-title":"Predictors and clinical outcomes of vasoplegia in patients bridged to heart transplantation with continuous-flow left ventricular assist devices","volume":"8","author":"Asleh","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2025.01.012_bib0036","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.athoracsur.2017.09.039","article-title":"Characterizing predictors and severity of vasoplegia syndrome after heart transplantation","volume":"105","author":"Chan","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0037","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.21037\/jtd.2020.03.53","article-title":"Vasoplegia following heart transplantation and left ventricular assist device explant is not associated with inferior outcomes","volume":"12","author":"Ali","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1053\/j.jvca.2025.01.012_bib0038","first-page":"406","article-title":"Severe vasoplegic shock after heart transplant successfully treated with multimodal therapeutic approach","volume":"22","author":"Jenkins","year":"2024","journal-title":"Exp Clin Transplant"},{"key":"10.1053\/j.jvca.2025.01.012_bib0039","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.hrtlng.2016.06.004","article-title":"Systemic inflammatory response syndrome (SIRS) after extracorporeal membrane oxygenation (ECMO): Incidence, risks and survivals","volume":"45","author":"Thangappan","year":"2016","journal-title":"Heart Lung"},{"key":"10.1053\/j.jvca.2025.01.012_bib0040","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/ajt.16010","article-title":"A change of heart: Preliminary results of the US 2018 adult heart allocation revision","volume":"20","author":"Goff","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1053\/j.jvca.2025.01.012_bib0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/fca-2021-0030","article-title":"Ex vivo normothermic perfusion in heart transplantation: A review of the TransMedics\u00ae Organ Care System","volume":"18","author":"Pinnelas","year":"2022","journal-title":"Fut Cardiol"},{"key":"10.1053\/j.jvca.2025.01.012_bib0042","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2022.07.024","article-title":"Hemodynamic and clinical performance of hearts donated after circulatory death","volume":"80","author":"D'Alessandro","year":"2022","journal-title":"JACC"},{"key":"10.1053\/j.jvca.2025.01.012_bib0043","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.healun.2024.02.1458","article-title":"Vasoplegic syndrome during heart transplantation: A systematic review and meta-analysis","volume":"43","author":"Kumar","year":"2024","journal-title":"J Heart Lung Transpl"},{"key":"10.1053\/j.jvca.2025.01.012_bib0044","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bja.2023.01.027","article-title":"Postoperative vasoplegia in lung transplantation: Incidence and relation to outcome in a single-centre retrospective study","volume":"130","author":"Verzelloni Sef","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0045","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1053\/j.jvca.2019.07.100","article-title":"Early post-operative vasoplegia in lung transplantation","volume":"33","author":"Manikavasagar","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0046","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/aca.aca_276_20","article-title":"Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series","volume":"26","author":"Washington","year":"2023","journal-title":"Ann Card Anaesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0047","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1213\/XAA.0000000000000190","article-title":"Methylene blue for vasoplegia when on cardiopulmonary bypass during double-lung transplantation","volume":"5","author":"Carley","year":"2015","journal-title":"A & A Case Rep"},{"key":"10.1053\/j.jvca.2025.01.012_bib0048","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1053\/j.jvca.2023.08.136","article-title":"Incidence of intraoperative vasoplegic syndrome in bilateral lung transplantation","volume":"37","author":"Lam","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6610754","article-title":"The use of methylene blue during liver transplantation for vasoplegia. Bele S, ed","volume":"2021","author":"Harding","year":"2021","journal-title":"Case Rep Anesthesiol"},{"key":"10.1053\/j.jvca.2025.01.012_bib0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1089253219842662","article-title":"Unexpected complication of hydroxocobalamin administration for refractory vasoplegia in orthotopic liver transplant: A case report","volume":"23","author":"Crouch","year":"2019","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0051","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.transproceed.2020.09.019","article-title":"Use of intravenous hydroxocobalamin for vasoplegic syndrome in simultaneous liver-kidney transplant: A case report","volume":"53","author":"Weinberg","year":"2021","journal-title":"Transpl Proc"},{"key":"10.1053\/j.jvca.2025.01.012_bib0052","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s40267-019-00643-7","article-title":"High-dose hydroxocobalamin in end-stage liver disease and liver transplantation","volume":"35","author":"Sakpal","year":"2019","journal-title":"Drugs Ther Perspect"},{"key":"10.1053\/j.jvca.2025.01.012_bib0053","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/TP.0000000000002344","article-title":"Efficacy of IgM-enriched immunoglobulin for vasopressor-resistant vasoplegic shock after liver transplantation","volume":"103","author":"Willuweit","year":"2019","journal-title":"Transplantation"},{"key":"10.1053\/j.jvca.2025.01.012_bib0054","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/ajt.14736","article-title":"Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation","volume":"18","author":"An","year":"2018","journal-title":"Am J Transpl"},{"key":"10.1053\/j.jvca.2025.01.012_bib0055","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1213\/ane.0b013e3181a286fc","article-title":"Vasoplegic syndrome during liver transplantation","volume":"108","author":"Cao","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0056","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S0102-86502016001300001","article-title":"Vasoplegic endothelial dysfunction in orthotopic liver transplantation","volume":"31","author":"Evora","year":"2016","journal-title":"Acta Cir Bras"},{"key":"10.1053\/j.jvca.2025.01.012_bib0057","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s12630-019-01449-x","article-title":"Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: A narrative review of cases and potential biochemical mechanisms","volume":"66","author":"Charles","year":"2019","journal-title":"Can J Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2022.107488","article-title":"Hydroxocobalamin for treatment of catecholamine-resistant vasoplegia during liver transplantation: A single-center series of 20 cases","volume":"98","author":"Boettcher","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"10.1053\/j.jvca.2025.01.012_bib0059","doi-asserted-by":"crossref","first-page":"e15271","DOI":"10.1111\/ctr.15271","article-title":"Use of hydroxocobalamin to treat intraoperative vasoplegic syndrome refractory to vasopressors and methylene blue during liver transplantation","volume":"38","author":"Pai","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2025.01.012_bib0060","doi-asserted-by":"crossref","first-page":"14977","DOI":"10.1111\/pan.14977","article-title":"Perioperative management of pediatric combined heart and liver transplantation: A 17 year single center experience","author":"Navaratnam","year":"2024","journal-title":"Pediatr Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0061","doi-asserted-by":"crossref","first-page":"e15302","DOI":"10.1111\/ctr.15302","article-title":"Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study","volume":"38","author":"Vaikunth","year":"2024","journal-title":"Clin Transpl"},{"key":"10.1053\/j.jvca.2025.01.012_bib0062","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006023","article-title":"Signaling in muscle contraction","volume":"7","author":"Kuo","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1053\/j.jvca.2025.01.012_bib0063","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","article-title":"Vasopressin: Mechanisms of action on the vasculature in health and in septic shock","volume":"35","author":"Barrett","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0064","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ki.1990.165","article-title":"Interaction of arginine vasopressin and angiotensin II on Ca2+ in vascular smooth muscle cells","volume":"38","author":"Caramelo","year":"1990","journal-title":"Kidney Int"},{"key":"10.1053\/j.jvca.2025.01.012_bib0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0022-4804(83)90066-5","article-title":"Changes in alpha-adrenergic receptors in dog livers during endotoxic shock","volume":"34","author":"Ghosh","year":"1983","journal-title":"J Surg Res"},{"key":"10.1053\/j.jvca.2025.01.012_bib0066","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc12809","article-title":"The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension","volume":"17","author":"Mederle","year":"2013","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.012_bib0067","doi-asserted-by":"crossref","first-page":"29541","DOI":"10.1074\/jbc.270.49.29541","article-title":"The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B","volume":"270","author":"Spink","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2025.01.012_bib0068","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1124\/mol.105.017467","article-title":"Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells","volume":"68","author":"Tang","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1053\/j.jvca.2025.01.012_bib0069","doi-asserted-by":"crossref","first-page":"H1953","DOI":"10.1152\/ajpheart.01193.2006","article-title":"Hydrogen sulfide mediates vasoactivity in an O2-dependent manner","volume":"292","author":"Koenitzer","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.jvca.2025.01.012_bib0070","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s40618-020-01465-5","article-title":"Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass","volume":"44","author":"Pasero","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/j.jvca.2025.01.012_bib0071","doi-asserted-by":"crossref","first-page":"e0687","DOI":"10.1097\/CCE.0000000000000687","article-title":"Protocol compliance guiding angiotensin II use in post cardiovascular surgery vasoplegia","volume":"4","author":"Ten Lohuis","year":"2022","journal-title":"Crit Care Explorations"},{"key":"10.1053\/j.jvca.2025.01.012_bib0072","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0073","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/aca.ACA_83_18","article-title":"Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension","volume":"22","author":"Abdelazziz","year":"2019","journal-title":"Ann Card Anaesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0074","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42077-020-0054-6","article-title":"Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: A randomized controlled study","volume":"12","author":"Saleh","year":"2020","journal-title":"Ain-Shams J Anesthesiol"},{"key":"10.1053\/j.jvca.2025.01.012_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.012_bib0076","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: The SEPSIS-ACT randomized clinical trial","volume":"322","author":"Laterre","year":"2019","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2025.01.012_bib0077","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: A systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2025.01.012_bib0078","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/j.jvca.2023.12.016","article-title":"Clinical adverse effects associated with non-catecholamine pharmacological agents for treatment of vasoplegic syndrome in adult cardiac surgery","volume":"38","author":"Hwang","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0079","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1067\/mtc.2001.115153","article-title":"Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation","volume":"122","author":"Kofidis","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: Early administration improves survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0081","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/aca.ACA_237_16","article-title":"Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study","volume":"20","author":"Mazzeffi","year":"2017","journal-title":"Ann Card Anaesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0082","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/jcm11041121","article-title":"Early use of methylene blue in vasoplegic syndrome: A 10-year propensity score-matched cohort study","volume":"11","author":"Kofler","year":"2022","journal-title":"JCM"},{"key":"10.1053\/j.jvca.2025.01.012_bib0083","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1053\/j.jvca.2023.04.006","article-title":"Hydroxocobalamin for vasodilatory hypotension in shock: A systematic review with meta-analysis for comparison to methylene blue","volume":"37","author":"Brokmeier","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0084","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1053\/j.jvca.2023.07.015","article-title":"Hydroxocobalamin versus methylene blue for the treatment of vasoplegic shock associated with cardiopulmonary bypass","volume":"37","author":"Hiruy","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0085","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00000539-200204000-00009","article-title":"The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation","volume":"94","author":"Koelzow","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0086","unstructured":"Provayblue FDA package insert https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/204630s000lbl.pdf.:9, 2023. Accessed 11\/5\/23"},{"key":"10.1053\/j.jvca.2025.01.012_bib0087","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1213\/01.ANE.0000153497.60047.80","article-title":"Severe anaphylactic shock with methylene blue instillation","volume":"101","author":"Dewachter","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0088","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/BF01700666","article-title":"Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock","volume":"21","author":"Gachot","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0089","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3389\/fgene.2019.00871","article-title":"The impact of CYP3A4*22 on tacrolimus pharmacokinetics and outcome in clinical practice at a single kidney transplant center","volume":"10","author":"Abdel-Kahaar","year":"2019","journal-title":"Front Genet"},{"key":"10.1053\/j.jvca.2025.01.012_bib0090","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/ctr.12790","article-title":"CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients","volume":"30","author":"Deininger","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2025.01.012_bib0091","doi-asserted-by":"crossref","first-page":"21389","DOI":"10.1038\/s41598-021-00942-y","article-title":"CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients","volume":"11","author":"D\u00e9ri","year":"2021","journal-title":"Sci Rep"},{"key":"10.1053\/j.jvca.2025.01.012_bib0092","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/FPC.0000000000000472","article-title":"Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients","volume":"32","author":"Liu","year":"2022","journal-title":"Pharmacogenet Genom"},{"key":"10.1053\/j.jvca.2025.01.012_bib0093","unstructured":"Retrieved from: Cyanokit FDA Package Insert. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/022041lbl.pdf. Accessed 11\/10\/23"},{"key":"10.1053\/j.jvca.2025.01.012_bib0094","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.freeradbiomed.2009.03.017","article-title":"Inhibition of nitric oxide synthase by cobalamins and cobinamides","volume":"46","author":"Weinberg","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0095","doi-asserted-by":"crossref","first-page":"20831","DOI":"10.1038\/srep20831","article-title":"Hydrogen sulfide\u2014mechanisms of toxicity and development of an antidote","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1053\/j.jvca.2025.01.012_bib0096","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.athoracsur.2013.08.050","article-title":"The use of high-dose hydroxocobalamin for vasoplegic syndrome","volume":"97","author":"Roderique","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0097","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12630-017-1029-3","article-title":"Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: A case series","volume":"65","author":"Shah","year":"2018","journal-title":"Can J Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0098","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/j.jvca.2023.03.017","article-title":"Seeing red: Hydroxocobalamin and result interference","volume":"37","author":"Ortoleva","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0099","unstructured":"Giapreza Highlights of Prescribing Information, FDA document. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209360s000lbl.pdf Accessed 11\/20\/23"},{"key":"10.1053\/j.jvca.2025.01.012_bib0100","first-page":"685","article-title":"Angiotensin II brings more questions than answers","volume":"43","author":"Farina","year":"2018","journal-title":"P T"},{"key":"10.1053\/j.jvca.2025.01.012_bib0101","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jtcvs.2021.02.097","article-title":"Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients","volume":"163","author":"Chow","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: A post-hoc analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0103","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1053\/j.jvca.2020.07.087","article-title":"Angiotensin II for critically ill patients with shock after heart transplant","volume":"35","author":"Cutler","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0104","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1053\/j.jvca.2024.02.028","article-title":"Diagnosis and management of vasoplegia in temporary mechanical circulatory support: A narrative review","volume":"38","author":"Ortoleva","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154369","article-title":"Intravenous vitamin C for vasoplegia: A double-blinded randomised clinical trial (VALENCIA trial)","volume":"78","author":"Anstey","year":"2023","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2025.01.012_bib0106","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1213\/XAA.0000000000000752","article-title":"Vitamin C for vasoplegia after cardiopulmonary bypass: A case series","volume":"11","author":"Wieruszewski","year":"2018","journal-title":"A & A Practice"},{"key":"10.1053\/j.jvca.2025.01.012_bib0107","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","article-title":"Intravenous vitamin C in adults with sepsis in the intensive care unit","volume":"386","author":"Lamontagne","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0108","unstructured":"ASCOR package insert. Manufactured by McGuff Pharmaceuticals, Inc., Santa Ana, CA. Retrieved from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209112s000lbl.pdf. Accessed 12\/20\/23"},{"key":"10.1053\/j.jvca.2025.01.012_bib0109","doi-asserted-by":"crossref","first-page":"NP01","DOI":"10.1093\/asj\/sju092","article-title":"Thiamine deficiency: A cause of profound hypotension and hypothermia after plastic surgery","volume":"35","author":"Gardiner","year":"2015","journal-title":"Aesthet Surg J"},{"key":"10.1053\/j.jvca.2025.01.012_bib0110","article-title":"Thiamine as an adjunctive therapy in cardiac surgery: A randomized, double-blind, placebo-controlled, phase II trial","volume":"14","author":"Andersen","year":"2016","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.012_bib0111","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2019.22176","article-title":"Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: The VITAMINS randomized clinical trial","volume":"323","author":"Fujii","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2025.01.012_bib0112","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jama.2020.24505","article-title":"Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: The VICTAS randomized clinical trial","volume":"325","author":"Sevransky","year":"2021","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2025.01.012_bib0113","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/01.HYP.27.2.228","article-title":"Indigo carmine inhibits endothelium-dependent and -independent vasodilation","volume":"27","author":"Chang","year":"1996","journal-title":"Hypertension"},{"key":"10.1053\/j.jvca.2025.01.012_bib0114","unstructured":"Retrieved from: Indigo Carmine FDA package insert. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/216264s000lbl.pdf. Accessed 12\/18\/23."},{"key":"10.1053\/j.jvca.2025.01.012_bib0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0116","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0117","doi-asserted-by":"crossref","unstructured":"Pirracchio R, Annane D, Waschka AK, et al. Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock. 2023;2. EVIDoa2300034","DOI":"10.1056\/EVIDoa2300034"},{"key":"10.1053\/j.jvca.2025.01.012_bib0118","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1053\/j.jvca.2019.08.013","article-title":"Elevated serum cobalt concentrations associated with hydroxocobalamin administration for refractory vasoplegia","volume":"33","author":"Seelhammer","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0119","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1053\/j.jvca.2019.08.033","article-title":"Cobalt blues: A new complication of hydroxocobalamin therapy for vasopressor-resistant vasoplegia in patients treated with chronic renal replacement therapy?","volume":"33","author":"Pagel","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8090-5-17","article-title":"Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting: A double-blind, randomized study","volume":"5","author":"Papadopoulos","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0121","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"Maslow","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0122","article-title":"Hydroxocobalamin versus methylene blue for treatment of vasoplegic shock following cardiopulmonary bypass: A systematic review and meta-analysis","volume":"5","author":"Cadd","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0123","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1053\/j.jvca.2022.01.021","article-title":"Predicting the response of hydroxocobalamin in postoperative vasoplegia in recipients of cardiopulmonary bypass","volume":"36","author":"Vollmer","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0124","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13054-019-2337-5","article-title":"Angiotensin II in ECMO patients: A word of caution","volume":"23","author":"Antonucci","year":"2019","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.012_bib0125","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1053\/j.jvca.2022.01.002","article-title":"Angiotensin II in patients with shock on mechanical circulatory support: A single-center retrospective case series","volume":"36","author":"Mohamed","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0126","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.5856","article-title":"Inhaled pulmonary vasodilator therapy in adult lung transplant: A randomized clinical trial","volume":"157","author":"Ghadimi","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1053\/j.jvca.2025.01.012_bib0127","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1053\/j.jvca.2019.03.004","article-title":"Synthetic human angiotensin II for postcardiopulmonary bypass vasoplegic shock","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0128","doi-asserted-by":"crossref","DOI":"10.1097\/01.ccm.0000812260.43290.ab","article-title":"1484: Methylene blue and hydroxocobalamin in a severely vasoplegic lung transplant recipient","volume":"50","author":"Olson","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.01.012_bib0129","unstructured":"Gordon DM, Nguyen A, Bouajram R, et al. Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series. Retrieved from: https:\/\/www.atsjournals.org\/doi\/10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A2970 [Accessed: 1\/20\/24]"},{"key":"10.1053\/j.jvca.2025.01.012_bib0130","doi-asserted-by":"crossref","first-page":"e1572","DOI":"10.1097\/TXD.0000000000001572","article-title":"The association of post-lung transplant pulmonary embolism with the development of chronic lung allograft dysfunction","volume":"10","author":"Magin","year":"2024","journal-title":"Transpl Direct"},{"key":"10.1053\/j.jvca.2025.01.012_bib0131","first-page":"247","article-title":"Hydroxocobalamin for vasoplegic syndrome in liver transplantation: Restoration of blood pressure without vasospasm","volume":"7","author":"Woehlck","year":"2016","journal-title":"A&A Case Rep"},{"key":"10.1053\/j.jvca.2025.01.012_bib0132","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jclinane.2011.10.010","article-title":"The response to methylene blue in patients with severe hypotension during liver transplantation","volume":"24","author":"Cheng","year":"2012","journal-title":"J Clin Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0133","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.jvca.2008.07.015","article-title":"Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation","volume":"24","author":"Fischer","year":"2010","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.01.012_bib0134","doi-asserted-by":"crossref","first-page":"e01402","DOI":"10.1213\/XAA.0000000000001402","article-title":"Intraoperative use of angiotensin ii for severe vasodilatory shock during liver transplantation: A case report","volume":"15","author":"Running","year":"2021","journal-title":"A&A Practice"},{"key":"10.1053\/j.jvca.2025.01.012_bib0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078713","article-title":"Angiotensin II in liver transplantation (AngLT-1): Protocol of a randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bokoch","year":"2023","journal-title":"BMJ Open"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025000400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025000400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:38:52Z","timestamp":1744385932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077025000400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":135,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1053077025000400"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2025.01.012","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasoplegia in Heart, Lung, or Liver Transplantation: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2025.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}